Inflammation in Parkinson’s Disease: Mechanisms and Therapeutic Implications
Parkinson’s disease (PD) is a common neurodegenerative disorder primarily characterized by the death of dopaminergic neurons that project from the substantia nigra <i>pars compacta</i>. Although the molecular bases for PD development are still little defined, extensive evidence from huma...
Main Authors: | Marta Pajares, Ana I. Rojo, Gina Manda, Lisardo Boscá, Antonio Cuadrado |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/7/1687 |
Similar Items
-
Gene-Based Therapeutics for Parkinson’s Disease
by: Karim E. Shalaby, et al.
Published: (2022-07-01) -
Differential profiles of serum cytokines in Parkinson's disease according to disease duration
by: Giulia Di Lazzaro, et al.
Published: (2024-01-01) -
Microglia: roles and genetic risk in Parkinson’s disease
by: Alex R. Trainor, et al.
Published: (2024-11-01) -
Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson’s Disease: A New Therapeutic Strategy
by: Mercè Pallàs, et al.
Published: (2020-05-01) -
Inflammation and heterogeneity in synucleinopathies
by: Antoine Freuchet, et al.
Published: (2024-08-01)